Cargando…
Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington’s disease
Huntington’s disease is a progressive neurodegenerative disorder characterized by motor, cognitive and psychiatric symptoms. Currently, no disease-modifying therapies are available to slow or halt disease progression. Huntington’s disease is characterized by relatively focal and specific loss of str...
Autores principales: | Drew, Cheney J G, Sharouf, Feras, Randell, Elizabeth, Brookes-Howell, Lucy, Smallman, Kim, Sewell, Bernadette, Burrell, Astrid, Kirby, Nigel, Mills, Laura, Precious, Sophie, Pallmann, Philip, Gillespie, David, Hood, Kerry, Busse, Monica, Gray, William P, Rosser, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850012/ https://www.ncbi.nlm.nih.gov/pubmed/33543141 http://dx.doi.org/10.1093/braincomms/fcaa230 |
Ejemplares similares
-
HD-DRUM, a Tablet-Based Drumming Training App Intervention for People With Huntington Disease: App Development Study
por: Metzler-Baddeley, Claudia, et al.
Publicado: (2023) -
Monitoring and Managing Lifestyle Behaviors Using Wearable Activity Trackers: Mixed Methods Study of Views From the Huntington Disease Community
por: Morgan-Jones, Philippa, et al.
Publicado: (2022) -
A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD)
por: Yhnell, Emma, et al.
Publicado: (2020) -
Exploring computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD): protocol for a randomised feasibility study
por: Yhnell, Emma, et al.
Publicado: (2018) -
Do foetal transplant studies continue to be justified in Huntington’s disease?
por: Bartley, Oliver J.M., et al.
Publicado: (2021)